Omega Therapeutics Corp (OMGA) Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi

Omega Therapeutics Corp - OMGA emitenti grafik logotipi

Omega Therapeutics mRNA kontrollerlarini yaratish uchun noyob IT infratuzilmasiga tayanadi, bu esa patentlar va FDA ning qat'iy nazorati ostidagi ta'sirli lobbi tomonidan himoyalangan. Ushbu narxlar grafigi joriy 0.00 ko'rsatkichini tasdiqlaydi. Biznes biotexnologiya gigantlari bilan intellektual mulk bo'yicha shiddatli kurashga duch kelmoqda, shu bilan birga saraton terapiyasi va to'qimalarni regeneratsiya qilish uchun innovatsion genlarni boshqarish usullarini ishlab chiqmoqda.

Omega Therapeutics (OMGA): Uzoq muddatli qarzning o'z kapitaliga nisbati 04.07.2022dan 08.03.2025gacha
Omega brend mahsuloti

Omega Therapeutics kompaniyasining kengaytiriladigan RNA platformasi yangi dori vositalarini ishlab chiqishdagi kapital xarajatlarini sezilarli darajada optimallashtiradi. Uzoq muddatli qarzlarning kapitalga nisbati kompaniyaning moliyalashtirish tuzilmasida muddati bir yildan ortiq bo'lgan qarzlarning ulushini o'lchaydi. Ushbu ko'rsatkich moliyaviy barqarorlikni va haddan tashqari yuqori kredit yuklamasi xavfini belgilaydi. Uzoq muddatli qarzlarning kapitalga nisbatini tahlil qilish vaqtincha yuzaga kelgan tebranishlarni tizimli likvidlik inqirozidan ajratishga yordam beradi. Ushbu grafik dinamikasi investitsiya riski va o'sish potentsiali o'rtasidagi haqiqiy muvozanatni baholash imkonini beradi.

Muhim raqobatchilar

Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi TEM (Tempus)|Uzoq muddatli qarzning o'z kapitaliga nisbati Qiagen Group (QGEN)|Isis Pharmaceuticals - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati RGEN (Repligen Corporation)|Uzoq muddatli qarzning kapitalga nisbati aviditybiosciences.com RNA|CRSP - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati GeneDx Holdings|Ultragenyx Pharma (RARE) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Beam Tx|SRPT (Sarepta Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati twistbioscience.com TWST|Uzoq muddatli qarzning kapitalga nisbati TXG|Intellia Therapeutics Inc (NTLA) - Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati STOK (Stoke)|Uzoq muddatli qarzning kapitalga nisbati BioLife BLFS|WVE: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti MAZE (mazetx.com)|SION (Sionna Therapeutics) - Uzoq muddatli qarzning o'z kapitaliga nisbati|PRME: Uzoq muddatli kreditlarning kapitalga nisbati|TSHA (Taysha) - Uzoq muddatli qarzning kapitalga nisbati|QURE: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati MGTX|RGNX - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Solid Biosciences SLDB|Uzoq muddatli qarzning kapitalga koeffitsiyenti OCGN|Pacific Biosciences of California - Uzoq muddatli qarzning kapitalga nisbati|BNTC - Uzoq muddatli qarzning kapitalga nisbati|Design Therapeutics (DSGN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati RCKT (rocketpharma.com)|FDMT (4D Molecular Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Lexeo LXEO|Uzoq muddatli qarzning o'z kapitaliga nisbati KRRO (Korro Bio, Inc.)|Uzoq muddatli qarzning kapitalga nisbati Editas Corp (EDIT)|Silence Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati PRQR (ProQR)|Codexis Bio - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Sangamo Therapeutics Inc. SGMO|NAUT: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Metagenomi Therapeutics|Uzoq muddatli qarzning o'z kapitaliga nisbati Precision BioSciences|Generation Bio Corp (GBIO) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Boundless Bio (BOLD)|XCUR - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Imunon IMNN|PHIO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Mustang Bio Corp - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati TransCode Therapeutics (RNAZ)|BNGO: Uzoq muddatli qarzning kapitalga nisbati|Applied DNA Sciences Inc (APDN) - Uzoq muddatli qarzning kapitalga nisbati|BLUE (Bluebird Bio) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi IPA (ImmunoPrecise)|Uzoq muddatli qarzning o'z kapitaliga nisbati Singular Genomics Systems (OMIC)|regulusrx.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati SYRS (Syros Pharmaceuticals, Inc.)|Uzoq muddatli qarzning kapitalga nisbati Telesis Bio Inc. TBIO|TCON - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Unity Biotechnology, Inc